Everuximab: a relief strategy for gastrointestinal discomfort

As an innovative humanized anti-ANGPTL3 monoclonal antibody, Evinacumab is widely used in the treatment of refractory hypercholesterolemia, especially homozygous familial hypercholesterolemia (HoFH). However, like many other drugs, everevumab may also cause some adverse reactions during use, of which gastrointestinal discomfort is a common one.

For patients with sensitive gastrointestinal tracts, it is recommended to take evesumumab after meals to reduce the direct irritation of the drug to the gastric mucosa. Taking medication after meals can buffer the direct effects of the medication and reduce gastrointestinal discomfort.

For patients who require larger doses of medication, consider dividing a single dose into multiple doses to reduce the impact of a single dose on the gastrointestinal tract. However, it should be noted that this method needs to be carried out under the guidance of a doctor to ensure that the efficacy of the drug is not affected.

During treatment, patients should choose light, easy-to-digest foods and avoid spicy, greasy, and irritating foods to reduce the burden on the gastrointestinal tract.

Maintaining adequate fluid intake can help promote drug metabolism and excretion while relieving gastrointestinal discomfort. However, it should be noted that excessive drinking of water may also increase the burden on the gastrointestinal tract, so you should drink moderate amounts of water.

For patients with severe gastrointestinal discomfort, gastric mucosal protective agents, such as sucralfate, colloidal bismuth pectin, etc., can be used under the guidance of a doctor to protect the gastric mucosa and reduce drug damage to the gastric mucosa.

For patients with symptoms of hyperacidity, drugs such as proton pump inhibitors (PPI) or H2 receptor antagonists can be used to inhibit gastric acid secretion and relieve gastrointestinal discomfort.

Patients should closely observe changes in symptoms of gastrointestinal discomfort. If symptoms continue to worsen or new symptoms appear, they should seek medical treatment in time. Patients should regularly communicate with their doctors about treatment progress and adverse reactions so that doctors can adjust their treatment plans in a timely manner.

Reference materials:https://www.drugs.com/mtm/evinacumab.html

xa0